3D Neuroscience Market Analysis

Technology (Brain imaging, Neuro-Microscopy, Electrophysiology, Neuroproteomic)

Brain Imaging Segment in the 3D neuroscience market is estimated to hold 42% of the revenue share during the forecast period. The increased usage of brain imaging devices, including MRI, EEG, and CT scans, in hospitals, diagnostic centers, and ambulatory surgical centers has led to the diagnosis of neurological diseases. According to a report by NHS England and NHS Improvement in 2022, approximately 67,215 individuals were referred for brain MRI scans in March 2022 to diagnose cancer. Therefore, the rising adoption of brain imaging techniques has increased demand for imaging devices in the upcoming years.

End User (Hospital, Diagnostic Laboratories, Research and Academic Institutes)

Diagnostic Laboratories segment in the 3D neuroscience market is established to attain majority revenue share. The main drivers of the industry's expansion are the growing usage of neurological devices in diagnostic labs and growing public awareness of the advantages of early disease diagnosis. According to the Parkinson's Foundation, around 90,000 individuals receive a Parkinson's disease diagnosis each year. Diagnostic facilities frequently employ neurology instruments such as electroencephalograms (EEG), electromyograms (EMG), CT scans, MRIs, and others for diagnosis. Thus, it is anticipated that the development of robust, safe, and efficient neurological equipment will propel the market’s expansion.

Our in-depth analysis of the global market includes the following segments: